NAVIDEA BIOPHARMACEUTICALS, INC. Notes Payable, Current
NAVIDEA BIOPHARMACEUTICALS, INC. had Notes Payable, Current of $1.32 million as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2023-08-11
- 2023-06-30: Notes Payable, Current $1.32M.
- 2023-03-31: Notes Payable, Current $343.07K.
- 2022-12-31: Notes Payable, Current $543.61K.
- 2022-09-30: Notes Payable, Current $0.00.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2023-06-30 | $1.32M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $343.07K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $543.61K 10-Q · filed 2023-08-11 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $113.97K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $453.43K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $190.55K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $745.44K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $366.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $410.25K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $175.92K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $305.95K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $80.02K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $198.80K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $316.07K 10-K · filed 2020-03-18 | |
| 2018-09-30 | $2.16M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $2.20M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.28M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.35M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $1.98M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.00M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.10M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $51.96M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $51.65M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $51.65M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $50.18M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $333.33K 8-K · filed 2017-12-15 | |
| 2015-09-30 | $333.33K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $333.33K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $6.09M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.35M 10-K · filed 2016-03-23 | $4.38M 10-K · filed 2015-03-16 |
| 2014-09-30 | $2.73M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $782.51K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $4.10M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $1.69M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $80.82K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $2.77M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $2.76M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $2.43M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $2.34M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $1.66M 10-Q · filed 2012-05-10 | |
| 2011-06-30 | $9.07K 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $62.41K 10-Q · filed 2011-08-08 |